KOSDAQ · 389650 · Medical & precision devices · ₩389650

Nextbiomedical넥스트바이오메디컬

389650 · KOSDAQ · ₩389650 · 넥스트바이오메디컬

₩28,000▲ ₩850 (3.13%)End-of-day · Oct 27, 2026 · End-of-day prices.

Trade

Sell Buy

Filings

Investor relations (IR) event기업설명회(IR)개최Sep 11, 2026Open on DART
Investor relations (IR) event기업설명회(IR)개최Sep 1, 2026Open on DART
Amended: Quarterly report (Mar 2026)[기재정정]분기보고서 (2026.03)Aug 19, 2026Open on DART
Half-year report (Jun 2026)반기보고서 (2026.06)Aug 10, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 25, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 22, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 26, 2026Open on DART
Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 7, 2026Open on DART
Major management matter relevant to investors투자판단관련주요경영사항 (NexsphereF 일본 독점 판권 계약)Apr 9, 2026Open on DART
Annual general meeting results정기주주총회결과Mar 30, 2026Open on DART
Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Mar 20, 2026Open on DART
Audit report submitted감사보고서제출Mar 19, 2026Open on DART
Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
Notice of shareholders' meeting주주총회소집공고Mar 6, 2026Open on DART
Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Feb 6, 2026Open on DART
Shareholders' meeting called주주총회소집결의 (정기주주총회)Feb 6, 2026Open on DART
Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 6, 2026Open on DART
Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Feb 6, 2026Open on DART
Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 19, 2025Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 3, 2025Open on DART
Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 30, 2025Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 11, 2025Open on DART
Investor relations (IR) event기업설명회(IR)개최Sep 5, 2025Open on DART
Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Mar 31, 2025Open on DART
Annual general meeting results정기주주총회결과Mar 24, 2025Open on DART
Audit report submitted감사보고서제출Mar 13, 2025Open on DART
Annual report (Dec 2024)사업보고서 (2024.12)Mar 13, 2025Open on DART
Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Mar 11, 2025Open on DART
Notice of shareholders' meeting주주총회소집공고Mar 6, 2025Open on DART
[Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Feb 20, 2025Open on DART
Shareholders' meeting called주주총회소집결의Feb 12, 2025Open on DART
Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Feb 12, 2025Open on DART
Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 4, 2025Open on DART
Investor relations (IR) event기업설명회(IR)개최Dec 24, 2024Open on DART
Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2024Open on DART
5%+ holding report주식등의대량보유상황보고서(약식)Dec 4, 2024Open on DART
Other management matters기타경영사항(자율공시) (미국 식품 의약국 (FDA) 의료기기 (2등급) 품목허가 취득)Nov 28, 2024Open on DART
5%+ holding report주식등의대량보유상황보고서(약식)Nov 15, 2024Open on DART
Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 14, 2024Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 7, 2024Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 7, 2024Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 7, 2024Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2024Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2024Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 27, 2024Open on DART

Titles in Korean until English translations are added.

Also known as: Nextbiomedical / 넥스트바이오메디컬 / 389650 / KRX:389650

Source: KRX statistical information